1. Effects of Trastuzumab Emtansine (T‐DM1) on QT Interval and Safety of Pertuzumab Plus T‐DM1 in Patients With Previously Treated Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer. Issue 1 (26th February 2013) Authors: Gupta, Manish; Wang, Bei; Carrothers, Timothy J.; LoRusso, Patricia M.; Chu, Yu‐Waye; Shih, Ted; Loecke, David; Joshi, Amita; Saad, Ola; Yi, Joo‐Hee; Girish, Sandhya Journal: Clinical pharmacology in drug development Issue: Volume 2:Issue 1(2013:Jan.) Page Start: 11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗